NO20010940L - TAN-1057 derivater - Google Patents
TAN-1057 derivaterInfo
- Publication number
- NO20010940L NO20010940L NO20010940A NO20010940A NO20010940L NO 20010940 L NO20010940 L NO 20010940L NO 20010940 A NO20010940 A NO 20010940A NO 20010940 A NO20010940 A NO 20010940A NO 20010940 L NO20010940 L NO 20010940L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- tan
- disorders
- humans
- animals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19838998A DE19838998A1 (de) | 1998-08-27 | 1998-08-27 | Neue Naturstoffderivate |
| PCT/EP1999/006124 WO2000012484A1 (de) | 1998-08-27 | 1999-08-20 | Tan-1057 derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010940D0 NO20010940D0 (no) | 2001-02-23 |
| NO20010940L true NO20010940L (no) | 2001-04-23 |
Family
ID=7878913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010940A NO20010940L (no) | 1998-08-27 | 2001-02-23 | TAN-1057 derivater |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6617332B1 (no) |
| EP (1) | EP1117652B1 (no) |
| JP (1) | JP4533535B2 (no) |
| KR (1) | KR20010099629A (no) |
| CN (1) | CN1324348A (no) |
| AT (1) | ATE267816T1 (no) |
| AU (1) | AU759618B2 (no) |
| BG (1) | BG105275A (no) |
| BR (1) | BR9913337A (no) |
| CA (1) | CA2342102C (no) |
| DE (2) | DE19838998A1 (no) |
| EE (1) | EE200100125A (no) |
| ES (1) | ES2219105T3 (no) |
| HK (1) | HK1041884A1 (no) |
| HR (1) | HRP20010135A2 (no) |
| HU (1) | HUP0103316A3 (no) |
| ID (1) | ID28365A (no) |
| IL (1) | IL141325A0 (no) |
| NO (1) | NO20010940L (no) |
| NZ (1) | NZ510153A (no) |
| PL (1) | PL346143A1 (no) |
| SK (1) | SK2622001A3 (no) |
| TR (1) | TR200100637T2 (no) |
| WO (1) | WO2000012484A1 (no) |
| ZA (1) | ZA200101038B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1113008A1 (en) * | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| EP2679590A1 (en) * | 2007-12-20 | 2014-01-01 | Dr. Reddy's Laboratories Ltd. | Processes for the Preparation of Sitagliptin and Pharmaceutically acceptable Salts thereof |
| US8487126B2 (en) | 2009-10-15 | 2013-07-16 | The University Of Tokushima | Process for preparation of diethylenetriaminepentaacetic acid derivative, and diethylenetriaminepentaacetic acid derivative |
| CN102725274A (zh) | 2009-10-16 | 2012-10-10 | Rib-X制药公司 | 抗微生物化合物和其制备和使用方法 |
| ES2675798T3 (es) | 2009-10-16 | 2018-07-12 | Melinta Therapeutics, Inc. | Compuestos antimicrobianos y métodos para fabricar y usar los mismos |
| CN104628729B (zh) * | 2009-10-16 | 2018-11-06 | 梅琳塔治疗公司 | 抗微生物化合物和其制备和使用方法 |
| MX359743B (es) | 2009-10-16 | 2018-10-08 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos para fabricar y utilizar los mismos. |
| ES2665988T3 (es) | 2011-04-15 | 2018-04-30 | Melinta Therapeutics, Inc. | Compuestos antimicrobianos y métodos de fabricación y uso de los mismos |
| RU2475479C1 (ru) * | 2011-12-23 | 2013-02-20 | Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) | Вазоконстрикторное средство |
| MX2016003046A (es) | 2013-09-09 | 2016-09-08 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. |
| KR20160070066A (ko) | 2013-09-09 | 2016-06-17 | 멜린타 테라퓨틱스, 인크. | 항균 화합물, 및 이의 제조 방법 및 이용 방법 |
| BR112017019349A2 (pt) | 2015-03-11 | 2018-06-05 | Melinta Therapeutics Inc | compostos antimicrobianos e métodos de fabricação e uso dos mesmos |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) * | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| US6110925A (en) | 1997-08-07 | 2000-08-29 | Research Corporation Technologies, Inc. | Antibiotic for methicillin resistant bacteria |
-
1998
- 1998-08-27 DE DE19838998A patent/DE19838998A1/de not_active Ceased
-
1999
- 1999-08-20 JP JP2000567514A patent/JP4533535B2/ja not_active Expired - Fee Related
- 1999-08-20 CA CA002342102A patent/CA2342102C/en not_active Expired - Fee Related
- 1999-08-20 DE DE59909607T patent/DE59909607D1/de not_active Expired - Lifetime
- 1999-08-20 BR BR9913337-7A patent/BR9913337A/pt not_active IP Right Cessation
- 1999-08-20 SK SK262-2001A patent/SK2622001A3/sk unknown
- 1999-08-20 ES ES99968234T patent/ES2219105T3/es not_active Expired - Lifetime
- 1999-08-20 AU AU10099/00A patent/AU759618B2/en not_active Ceased
- 1999-08-20 ID IDW20010483A patent/ID28365A/id unknown
- 1999-08-20 IL IL14132599A patent/IL141325A0/xx unknown
- 1999-08-20 HU HU0103316A patent/HUP0103316A3/hu unknown
- 1999-08-20 KR KR1020017002417A patent/KR20010099629A/ko not_active Application Discontinuation
- 1999-08-20 PL PL99346143A patent/PL346143A1/xx not_active Application Discontinuation
- 1999-08-20 CN CN99812643A patent/CN1324348A/zh active Pending
- 1999-08-20 NZ NZ510153A patent/NZ510153A/xx unknown
- 1999-08-20 EP EP99968234A patent/EP1117652B1/de not_active Expired - Lifetime
- 1999-08-20 US US09/763,711 patent/US6617332B1/en not_active Expired - Fee Related
- 1999-08-20 TR TR2001/00637T patent/TR200100637T2/xx unknown
- 1999-08-20 EE EEP200100125A patent/EE200100125A/xx unknown
- 1999-08-20 WO PCT/EP1999/006124 patent/WO2000012484A1/de not_active Application Discontinuation
- 1999-08-20 AT AT99968234T patent/ATE267816T1/de not_active IP Right Cessation
-
2001
- 2001-02-07 ZA ZA200101038A patent/ZA200101038B/en unknown
- 2001-02-20 BG BG105275A patent/BG105275A/xx unknown
- 2001-02-23 NO NO20010940A patent/NO20010940L/no unknown
- 2001-02-26 HR HR20010135A patent/HRP20010135A2/hr not_active Application Discontinuation
-
2002
- 2002-05-17 HK HK02103758.4A patent/HK1041884A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6617332B1 (en) | 2003-09-09 |
| JP2002523496A (ja) | 2002-07-30 |
| EE200100125A (et) | 2002-06-17 |
| BG105275A (en) | 2001-11-30 |
| HRP20010135A2 (en) | 2002-02-28 |
| HK1041884A1 (zh) | 2002-07-26 |
| AU1009900A (en) | 2000-03-21 |
| IL141325A0 (en) | 2002-03-10 |
| NO20010940D0 (no) | 2001-02-23 |
| KR20010099629A (ko) | 2001-11-09 |
| SK2622001A3 (en) | 2001-11-06 |
| EP1117652B1 (de) | 2004-05-26 |
| JP4533535B2 (ja) | 2010-09-01 |
| ES2219105T3 (es) | 2004-11-16 |
| WO2000012484A1 (de) | 2000-03-09 |
| DE19838998A1 (de) | 2000-03-09 |
| NZ510153A (en) | 2002-12-20 |
| CA2342102C (en) | 2008-10-28 |
| PL346143A1 (en) | 2002-01-28 |
| TR200100637T2 (tr) | 2001-10-22 |
| ZA200101038B (en) | 2002-02-07 |
| ID28365A (id) | 2001-05-17 |
| AU759618B2 (en) | 2003-04-17 |
| EP1117652A1 (de) | 2001-07-25 |
| DE59909607D1 (de) | 2004-07-01 |
| BR9913337A (pt) | 2001-05-15 |
| HUP0103316A3 (en) | 2002-06-28 |
| HUP0103316A2 (hu) | 2002-04-29 |
| ATE267816T1 (de) | 2004-06-15 |
| CN1324348A (zh) | 2001-11-28 |
| CA2342102A1 (en) | 2000-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY124122A (en) | Heterocyclic derivatives | |
| DK1200418T3 (da) | Nematodicide trifluorbutener | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
| MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
| DE60003863D1 (de) | Dioxocyclopentylhydroxamsäure | |
| ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
| YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
| GB9715894D0 (en) | Heterocyclic derivatives | |
| MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
| NO20010940L (no) | TAN-1057 derivater | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| GB9809349D0 (en) | Heterocyclic derivatives | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| MXPA04001328A (es) | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. | |
| MXPA04005552A (es) | Analogos de vitamina d. | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| DE69402004T2 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen | |
| MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. | |
| PT1232173E (pt) | Derivados do acido fusidico | |
| CO5150221A1 (es) | Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas | |
| SE9803277D0 (sv) | Novel compounds | |
| DK0580624T3 (da) | Hidtil ukendte cytarabinderivater, fremstilling og anvendelse deraf |